| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/15/1997 | US5648092 Antiulcer |
| 07/15/1997 | US5648091 Tocopherol |
| 07/15/1997 | US5648090 Liposome encapsulated toxol and a method of using the same |
| 07/15/1997 | US5648087 Phencyclidine anesthetic |
| 07/15/1997 | US5648080 Antigenic preparations and isolation of such preparations |
| 07/15/1997 | US5648071 Method of treating tumors |
| 07/15/1997 | US5648067 Bactericides |
| 07/15/1997 | CA2069063C Processes for the diastereoselective synthesis of nucleosides |
| 07/12/1997 | CA2194730A1 Topical compositions for the treatment of skin diseases |
| 07/10/1997 | WO1997024445A1 Recombinant fusion proteins to growth hormone and serum albumin |
| 07/10/1997 | WO1997024443A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 07/10/1997 | WO1997024441A1 Nucleic acids encoding interferon gamma inducing factor-2 |
| 07/10/1997 | WO1997024440A1 Ob protein derivatives having prolonged half-life |
| 07/10/1997 | WO1997024438A1 Immunostimulatory composition and method |
| 07/10/1997 | WO1997024374A1 Stable solution containing sodium hyaluronate |
| 07/10/1997 | WO1997024369A1 Growth-hormone secretagogues |
| 07/10/1997 | WO1997024368A1 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio-androstane derivatives (17beta-(gamma-butyric acid lactone)-thio derivatives) for the treatment of inflammation and pharmaceutical compositions and a process for the production thereof |
| 07/10/1997 | WO1997024367A1 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them |
| 07/10/1997 | WO1997024366A1 Sodium pump inhibitor compounds and their binding partners |
| 07/10/1997 | WO1997024365A1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives |
| 07/10/1997 | WO1997024363A1 Novel a1 adenosine receptor agonists and antagonists |
| 07/10/1997 | WO1997024359A1 Novel cephalosporin derivatives and processes for the preparation thereof |
| 07/10/1997 | WO1997024358A1 Process for preparation of cefdinir |
| 07/10/1997 | WO1997024356A1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
| 07/10/1997 | WO1997024355A1 Pyrido (2,3-b) pyrazine derivatives |
| 07/10/1997 | WO1997024354A1 Substituted 6-r-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them |
| 07/10/1997 | WO1997024353A1 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them |
| 07/10/1997 | WO1997024352A1 Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as an aesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them |
| 07/10/1997 | WO1997024350A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 07/10/1997 | WO1997024349A1 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists |
| 07/10/1997 | WO1997024348A1 ((3'-thioxacyclohex-1'-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/10/1997 | WO1997024343A1 Phenyl thiazole derivatives with anti herpes virus properties |
| 07/10/1997 | WO1997024342A1 Thiol derivatives with metallopeptidase inhibitory activity |
| 07/10/1997 | WO1997024340A1 Oxazole derivatives, their production and use |
| 07/10/1997 | WO1997024334A1 Benzimidazole derivatives |
| 07/10/1997 | WO1997024333A1 Preventives/remedies for complications of diabetes |
| 07/10/1997 | WO1997024328A1 2-amino-heterocycles and therapeutic uses therefor |
| 07/10/1997 | WO1997024324A1 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 07/10/1997 | WO1997024323A1 Process for the preparation of optically enriched 4-aryl-3-hydromethyl substituted piperidines to be used as intermediates in the synthesis of paroxetine |
| 07/10/1997 | WO1997024143A1 Cytotoxic agents |
| 07/10/1997 | WO1997024138A2 Medical use of proteases |
| 07/10/1997 | WO1997024135A1 Amidino protease inhibitors |
| 07/10/1997 | WO1997024134A1 A pharmaceutical composition comprising plant worms and muirapuama |
| 07/10/1997 | WO1997024133A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | WO1997024132A1 Allogeneic paracrine cytokine tumor vaccines |
| 07/10/1997 | WO1997024130A1 CANCEROUS METASTASIS INHIBITOR COMPRISING SURFACE POLYSACCHARIDE OF STREPTOCOCCUS AGALACTIAE Ia TYPE OR Ib TYPE AS PRINCIPAL COMPONENT |
| 07/10/1997 | WO1997024129A1 Pharmaceutical composition containing trehalose |
| 07/10/1997 | WO1997024128A1 Otic microbial combinations |
| 07/10/1997 | WO1997024126A1 Malignant tumor metastasis inhibitors |
| 07/10/1997 | WO1997024125A2 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol |
| 07/10/1997 | WO1997024124A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024123A1 Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye |
| 07/10/1997 | WO1997024122A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024121A1 Antiviral agent |
| 07/10/1997 | WO1997024120A1 THIENO(2,3-b)PYRAZOLO(3,4-d)PYRIDIN-3-ONES TO ENHANCE ERYTHROPOIESIS |
| 07/10/1997 | WO1997024119A1 Vitronectin receptor antagonists |
| 07/10/1997 | WO1997024118A1 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 07/10/1997 | WO1997024117A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 07/10/1997 | WO1997024116A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
| 07/10/1997 | WO1997024115A1 Naphthalenecarboxylic acid derivatives |
| 07/10/1997 | WO1997024114A1 Parenteral pharmaceutical compositions containing ammoniumalkyl salts of 2-arylpropionic acids |
| 07/10/1997 | WO1997024113A1 USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR THE PREPARATION OF A DRUG FOR RESPIRATORY STIMULATION |
| 07/10/1997 | WO1997024112A1 External preparation |
| 07/10/1997 | WO1997024111A2 Novel hyaluronic acid receptors binding agents and the use thereof |
| 07/10/1997 | WO1997024104A1 Cosmetic compositions for the hair or skin based on sulfone copolyesters with polyorganosiloxane units |
| 07/10/1997 | WO1997024030A1 Pyrrolidine derivatives |
| 07/10/1997 | WO1997015662A3 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
| 07/10/1997 | WO1997015555A3 Imidazole derivatives and the use thereof as nitrogen monoxide synthase inhibitors |
| 07/10/1997 | WO1997011682A3 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/10/1997 | WO1997009049A3 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 07/10/1997 | WO1997007769A3 Chemical compounds |
| 07/10/1997 | DE19601060A1 Neue monofunktionalisierte EDTA-, DTPA- und TTHA-Derivate und deren Verwendung in der medizinischen Diagnostik und Therapie New monofunctionalized EDTA, DTPA and TTHA derivatives and their use in medical diagnostics and therapy |
| 07/10/1997 | DE19600480A1 Verwendung von Serin-Proteinasen gegen Akne und entzündete Comedonen Use of serine proteinases against acne and inflamed comedones |
| 07/10/1997 | DE19600347A1 Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus Skin-adhesive pharmaceutical preparation, particularly TTS for the delivery of 17-beta-estradiol on the human organism |
| 07/10/1997 | DE19600301A1 Bioregulatorischer Wirkstoff, Verfahren zu seiner Herstellung sowie dessen Verwendung Bioregulatory active substance, process for its preparation and its use |
| 07/10/1997 | DE19549118A1 Use of guanidine or its derivatives to inhibit activation of haemostasis |
| 07/10/1997 | DE19548332A1 Hormonpflaster Hormone patches |
| 07/10/1997 | DE19547972A1 New use of heparin |
| 07/10/1997 | DE19544768C1 Verwendung einer Kombination aus Pentoxifyllin mit Typ-I-Interferonen zur Behandlung der Multiplen Sklerose Using a combination of pentoxifylline with type I interferons for the treatment of multiple sclerosis |
| 07/10/1997 | CA2254791A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | CA2241913A1 Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye |
| 07/10/1997 | CA2241758A1 Methods of treatment with compounds having rar.alpha. receptor specific or selective activity |
| 07/10/1997 | CA2241728A1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives |
| 07/10/1997 | CA2241724A1 Vitronectin receptor antagonists |
| 07/10/1997 | CA2241723A1 Thieno(2,3-b)pyrazolo(3,4-d)pyridin-3-ones to enhance erythropoiesis |
| 07/10/1997 | CA2241690A1 Pyrido(2,3-b)pyrazine derivatives |
| 07/10/1997 | CA2241633A1 Vitronectin receptor antagonists |
| 07/10/1997 | CA2241531A1 Use of inhibitors of the cellular na+/h+ exchanger (nhe) for the preparation of a drug for respiratory stimulation |
| 07/10/1997 | CA2241414A1 Thiol derivatives with metallopeptidase inhibitory activity |
| 07/10/1997 | CA2241373A1 Compositions and methods for t-cell activation comprising gm-csf and tumor antigen fusion proteins |
| 07/10/1997 | CA2241280A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 07/10/1997 | CA2241213A1 Antiviral agent |
| 07/10/1997 | CA2240578A1 Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells |
| 07/10/1997 | CA2240401A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/10/1997 | CA2240292A1 Recombinant fusion proteins to growth hormone and serum albumin |
| 07/10/1997 | CA2240278A1 Malignant tumor metastasis inhibitors |
| 07/10/1997 | CA2240266A1 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol |
| 07/10/1997 | CA2240257A1 A pharmaceutical composition comprising plant worms and muirapuama |
| 07/10/1997 | CA2238885A1 Nucleic acids encoding interferon gamma inducing factor-2 |
| 07/10/1997 | CA2238307A1 Ob protein derivatives having prolonged half-life |